In this webinar, NVHR and Treatment Action Group (TAG) discuss what it will take to make rapid HCV diagnostics a reality in the United States. Dr. Anne Gaynor from the Association of Public Health Laboratories (APHL) walks us through the FDA announcement to reclassify HCV diagnostics.
The CDC and APHL recently co-hosted webinars on “Identifying High-Priority Diagnostic Approaches for Advancing Hepatitis C Elimination in the US.” Check out the recordings here.